Performance

RLAY +237.02%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
RLAY	+9.62%	+141.02%	+237.02%	-10.48%	-28.15%	2.14	0.00%

Summary

RLAY at a glance

RLAY returned +237.02% over the past year and -10.48% a year over five years. Its worst drop in that year was -28.15%, smaller than 62% of stocks on Redstone, and its Sharpe ratio of 2.14 beats 98% of stocks on Redstone. It pays no dividends.

Ranking

How RLAY ranks

Current Drawdown

-1.73%

Rolling Volatility

74.32%

Actions

Metrics

Risk Indicators

Alpha123.65%

Beta1.59x

Sharpe2.14

Sortino3.70

Omega1.44

Calmar8.42

Martin13.26

Profile

About RLAY

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients.

Sector: Health Care
Industry: Biological Products, (no Diagnostic Substances)
Market cap: $4.5B
Listed: Jul 2020
Employees: 192
Headquarters: Cambridge, MA
Website: relaytx.com

Comparisons

RLAY: Relay Therapeutics, Inc.

RLAY at a glance

How RLAY ranks

Current Drawdown

Rolling Volatility

About RLAY

Related comparisons